Precision Biosciences Inc
DTIL· Nasdaq
DTILPrecision Biosciences Inc
Filed Aug 13, 2020 · 10-Q · 44 days after period end · 0001564590-20-039797
| Metric | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|
| Revenue | $1.08M | $5.39M | $1.87M |
| Net Income | -$32.70M | -$19.44M | -$11.83M |
| EPS Diluted | -$0.63 | -$0.39 | -$0.75 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Precision Biosciences Inc · CIK 1357874 · Engraved from SEC EDGAR
ended Jun 30, 2020 · filed Aug 13, 2020 · 44 d after period end
